-
27MayAngela had decided to take part in the 2.6 Challenge which started on 26th April, the date planned for the London Marathon, to raise money for Secondary1st. She had been treated for breast cancer in 2009 and then diagnosed with … Continue reading
-
04MayAngela had been treated for breast cancer in 2007 but was diagnosed with secondary breast cancer at the end of 2019. She wanted to raise money for research into the disease and decided to take part in the 2.6 challenge … Continue reading
-
24AprilOn Sunday 26th April, the date planned for the 2020 London Marathon, there is the opportunity for everyone to take up the 2.6 Challenge. This is a nationwide event inviting people all over the UK to take part in an … Continue reading
-
03AprilAs Trustees of Secondary1st we want to send our very best wishes to all our supporters and fundraisers and assure everyone that Secondary1st is in a stable financial position. We will survive through the current situation and emerge ready to … Continue reading
-
03AprilThe theatre company “Take Three Girls” toured Exmoor performing Alan Bennett’s “Her Big Chance” and publicising the work of the charity to raise money for Secondary1st in honour of the late Mary Richards. “Her Big Chance” is from the “Talking … Continue reading
-
03April
Michele planned to run a half-marathon and then a marathon this year after taking part in a 10k and a half-marathon in 2019 to raise money for Secondary1st. When both of this year’s events were postponed because of the Coronavirus … Continue reading
-
03AprilWhile everyone is encouraged to stay at home as much as possible and so many shops are closed more people are turning to on-line shopping. AmazonSmile makes no charge to the buyer, provides the same products at the same prices … Continue reading
-
03AprilBefore the lockdown, Andrea’s sisters and best friend managed to add three more challenges to their 40for40 campaign in Andrea’s memory. These were the shoeathon, which involved wearing 40 pairs of shoes, a metafit class and a friend duathalon and … Continue reading
-
17February
Researchers in the US have successfully conducted the first small-scale clinical trial to test a gene-editing treatment for cancer. They extracted t-cells, which are immune cells, from three cancer patients and edited their DNA with Crispr-Cas9, a powerful tool which … Continue reading
-
17February1300 researchers have worked for ten years to explore the entire cancer genome. Their results suggest that some cancers could be predicted through DNA mutations that occur many years before the cancers make patients ill. The Pan-Cancer Analysis of Whole … Continue reading
